Clinical Trial Update: PREVAIL VIIIa: Evaluation of Latent Tuberculosis Infection Screening Methods in People Living With Retroviral Infection in Liberia

View source ↗

Summary

NIAID-sponsored PREVAIL VIIIa trial evaluating latent tuberculosis infection screening methods in people living with HIV in Liberia; status: active but not recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Tuberculosis

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Tuberculosis, HIV | Status: ACTIVE_NOT_RECRUITING